Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05735743 · ClinicalTrials.gov registry record · NA

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

A NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.

Active
Registry status
NA
Development phase
176
Enrollment target
6
Study locations

NCT05735743 is a NA study of End Stage Renal Disease on Dialysis that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 176 participants, above the 58-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (203% higher). The trial reports 6 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05735743, a NA study of End Stage Renal Disease on Dialysis, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
176 participants
Enrollment target
6
Study locations

Study Summary

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Conditions Studied

End Stage Renal Disease on Dialysis

Interventions

  • BEHAVIORAL Motivational interviewing

Study Locations (6)

Pennsylvania

  • DaVita Philadelphia PMC Dialysis - Philadelphia
  • DaVita University City Dialysis - Philadelphia
  • Buttonwood DaVita Dialysis 449 N Broad St, - Philadelphia, PA 19123

Tennessee

  • Vanderbilt Dialysis Clinic - Nashville
  • Dialysis Clinic, Inc. - Nashville
  • Vanderbilt Dialysis Clinic East - Nashville

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2023-10-09
Est. Completion 2027-11-01
Phase NA

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05735743

The ClinicalTrials.gov registry entry for NCT05735743 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (203% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 1 intervention - of which Motivational interviewing is the first listed.

NCT05735743 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05735743 about?

NCT05735743 is a clinical study titled "MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence". MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical t...

What is the current status of trial NCT05735743?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2023-10-09. Estimated completion is 2027-11-01.

What conditions does trial NCT05735743 study?

This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.

What interventions are being tested in trial NCT05735743?

The interventions under investigation include: Motivational interviewing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05735743?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05735743 being conducted?

This trial has 6 study locations across Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease on Dialysis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease on Dialysis

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.